Recent Activity

CommentJun 28, 2019 - 12:00pm

ILR Comments to Federal Trade Commission on Consent Decrees

Comments submitted to the Federal Trade Commission in connection with hearings on competition and consumer protection in the 21st century.

CommentJun 03, 2019 - 12:00pm

Comments to CMS in response to Proposed Rule on Interoperability and Patient Access

This letter was submitted to the Centers for Medicare and Medicaid Services (CMS) in response to the Proposed Rule, which is intended to move the health care ecosystem in the direction of interoperability, and to improve the access to and quality of information that Americans need to make informed health care decisions.

CommentMay 31, 2019 - 9:45am

Chamber Comments to FTC On Data Privacy

U.S. Chamber Comments to the Federal Trade Commission supporting a national privacy framework.

CommentMay 01, 2019 - 4:15pm

U.S. Chamber Comments on REG-104464-18: Deduction for Foreign-Derived Intangible Income and Global Intangible Low-Taxed Income

On May 1, the U.S. Chamber submitted the following comments to the Treasury Department and the IRS on REG-104464-18, guidance to determine the amount of the deduction for foreign-derived intangible income and global intangible low-taxed income, as published in the Federal Register on March 6, 2019.

CommentApr 08, 2019 - 12:00pm

Comments to HHS Opposing Removal of Safe Harbor Protection for Rebates

This letter was submitted to the Department of Health and Human Services, supporting the removal of safe harbor protection for rebates involving prescription pharmaceuticals and creation of new safe harbor protections for certain point-of-sale reductions in price on prescription pharmaceuticals and certain pharmacy benefit manager service fees.